Mississauga, ON | 21 January 2025 Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is pleased to announce the approval of RayOne EMV Toric (RAO210T) by Health Canada. Developed in collaboration with Professor Graham Barrett, RayOne EMV and RayOne EMV Toric are the only patented aspheric IOLs that induce controlled

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is delighted to announce that it has now closed recruitment in the Investigational Device Exemption (IDE) study for the EMV Toric Intraocular lens in the USA. The study reflects Rayner’s continued focus on optimising visual outcomes for surgeons and their patients and

16 September 2022. Worthing, United Kingdom – Rayner, the pioneering manufacturer and supplier of ophthalmic solutions for cataract and refractive surgery, today announced that the world’s first implantations of RayOne EMV Toric had been performed by two highly respected surgeons from the UK. RayOne EMV Toric is the awaited toric variant of Rayner’s popular RayOne

Rayner will offer the most complete family of trifocal IOLs in the industry, allowing surgeons to treat an even wider range of presbyopic patients: Sulcoflex Trifocal, RayOne Trifocal and new RayOne Trifocal Toric. High patient satisfaction and spectacle independence reported from a multicentre pilot study. RayOne Trifocal Toric’s cylinder range starts from +0.75 D, allowing

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, announces today that its RayOne Galaxy and RayOne Galaxy Toric intraocular lenses are now available in Brazil. RayOne Galaxy, which saw a full commercial release in January 2025 following a highly successful multicenter study, sets a new standard for what surgeons can

6 May 2025 Rayner, a global provider of solutions for cataract surgery and the only manufacturer of intraocular lenses (IOLs) in the UK, proudly announces today that it has been honoured with the prestigious King’s Award for Enterprise 2025 for its innovative RayOne EMV increased range of focus IOL. RayOne EMV, which launched in 2020,

02 April 2025 | In response to demand growth, Rayner – a global leader in solutions for cataract surgery – has completed an extensive expansion of its Worthing (UK) production facility, doubling the number of intraocular lenses (IOLs) it can manufacture annually to 4 million. Since opening its purpose-built manufacturing facility in 2017, every Rayner

Rayner, a global manufacturer of products for cataract surgery, today announces the launch of its redesigned online premium IOL calculator, RayTrace. One of the first online IOL calculation tools, RayTrace has been trusted by surgeons globally since 2008 for the accuracy of its premium IOL (toric, multifocal and supplementary) calculations, and has delivered over 360,000

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, proudly announces delivery of its 5 millionth RayOne lens (and 11 millionth lens made from RayAcryl Rayner’s proprietary hydrophilic acrylic material), marking an important milestone in units sold globally. RayOne is Rayner’s fully-preloaded intraocular lens (IOL) injection system, providing smooth, consistent rolling

Worthing, United Kingdom – August 11, 2023: Rayner, a global ophthalmic leader in Devices, Drugs and Digital, is pleased to announce the successful completion of the first implantations in two pivotal market access studies in China and the USA. In April, Rayner received approval from the People’s Republic of China’s Ministry of Science and Technology

The first seven episodes of ‘Peer2Peer: The Podcast’ are now available, featuring Dr Lisa Nijm (USA), Dr Paul Singh (USA), Dr Stefanie Schmickler (Germany), Dr Josefina Botta (Argentina), Dr Karl Stonecipher (USA), Professor Graham Barrett (Australia), Mr Paul Rosen (UK), Mr Allon Barsam (UK), Mr Andrew Turnbull (UK), Dr Eric Donnenfeld (USA) and Dr Jerry

Rayner sponsors ESCRS satellite symposium When: Sunday 18th September, 13.00-14.00 Where: Room Blue 2 Professor Oliver Findl (Austria), Professor Gerd Auffarth (Germany), Mr Allon Barsam (United Kingdom), Dr Başak Bostanci (Turkey) and Dr Tiago Ferreira (Portugal) complete the panel of surgeons for the Rayner-sponsored satellite symposium: Challenges in cataract surgery and advanced technology IOL solutions.

JANUARY 19, 2022 – Worthing, United Kingdom. Rayner, a leading ophthalmology company and the only British manufacturer of intraocular lenses (IOLs), announced today that it now has a direct sales presence in Australia as it continues its global commercial expansion. Previously distributed through Designs For Vision, Rayner will now sell its products directly to surgeons and hospitals

DECEMBER 22, 2021 – Worthing, United Kingdom. Rayner, a leading UK-based ophthalmic company focused on optimising visual outcomes for surgeons and their patients, is delighted to announce the appointment of Drs Eric Donnenfeld, Kerry Solomon, Vance Thompson, and Mr Jim Mazzo as strategic advisors to the business, with a specific focus on supporting the expansion

Worthing, UK – Following the recent approval of incorporation, Rayner is proud to announce its direct entry into the Canadian ophthalmology market. Led by Wade Allen, Director: Americas, Rayner Surgical Corp will now be offering the Rayner portfolio of IOLs and injectors directly to Canadian surgeons. Rayner Surgical Corp has recently had the RayOne Aspheric

Worthing (UK) – Rayner, the manufacturer of the world’s first intraocular lens (IOL) and winner of the 2020 Queen’s Award for Enterprise (Innovation), announced today the launch of their updated web-based Premium IOL Calculator, Raytrace. Developed in line with surgeon feedback, the new Raytrace version 3.5 includes the following improvements: Inclusion of Posterior Corneal Astigmatism

Rayner hosted its first surgeon clinical education webinar on 27 May 2020, with attendees from over 47 countries. Over the course of one hour, the three presenters spoke about returning to clinic (including associated safety precautions), their experience with premium trifocal IOLs, and the utilisation of contactless telehealth. The webinar was concluded with a busy

Wednesday 27th May (1 hour) Join an international panel of expert speakers as they share their experiences with premium trifocal intraocular lenses (IOLs), and discuss the importance of Patient Reported Outcomes (PROs). The speakers will also talk about returning to clinic after COVID-19. The webinar will last 1 hour (includes 15-minute Question & Answer session).

Rayner are proud to announce the launch of the new, CE marked Sulcoflex Trifocal Pseudophakic Supplementary IOL at the 2018 ESCRS in Vienna

...

RayOne Hydrophobic, Rayner’s first fully preloaded IOL system with a hydrophobic acrylic lens, is now available to CE Mark-accepting countries. Daily compromises faced by cataract surgeons are eliminated with a new proprietary material, unique Cornerstone lens shape and intuitive fully preloaded injector. Worthing (UK), May 22nd, 2018 – Rayner, the manufacturer of the world’s first IOL,

Rayner, together with Iskowitz – Rayner’s exclusive distributor in Argentina -- announced today that the RayOne fully preloaded IOL injection...

18 January, 2018. Worthing, United Kingdom. Over the course of 2017, Rayner marked the 10-year anniversary for receiving CE approval for the following IOLs:

Rayner announced today that their new RayOne fully preloaded IOL injection system has received Central Drugs Standard Organisation (CDSCO) approval and is being launched in...

Rayner announced today the latest update in the RayOne story: registration of the RayOne Aspheric and Spheric monofocal fully preloaded IOL injection systems has been listed in the Federal Register by ANVISA, the Brazilian National Sanitary Sur...

March 02, 2017 – Worthing, United Kingdom. Rayner announced today that a selection of models in their Sulcoflex range of pseudophakic supplementary IOLs have received Chi...

Hosted by Professor Oliver Findl, from the Hanusch Hospital in Vienna, the XVI Rayner Forum centred around a theme of “Innovations and Controversies in Op...

Rayner’s growth strategy continues as the company announced today that the Egyptian Ministry of Health has approved the following IOLs for sale in Egypt:

• C-flex